Nathan Vandergrift

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys

Computational analysis of antibody dynamics identifies recent HIV-1 infection

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

HIV DNA-adenovirus multiclade envelope vaccine induces gp41 antibody immunodominance in rhesus macaques

Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120

Maternal humoral immune correlates of peripartum transmission of clade C HIV-1 in the setting of peripartum antiretrovirals

Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

HIV-1 envelope mimicry of host enzyme kynureninase does not disrupt tryptophan metabolism

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

Strain-specific V3 and CD4 binding site autologous HIV-1 neutralizing antibodies select neutralization-resistant viruses

HIV-1 vaccines. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

Comprehensive characterization of the transmitted/founder env genes from a single MSM cohort in China

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus, and trivalent mosaic envelope vaccines formulated as a DNA prime, NYVAC, and envelope protein boost